Clinical Trial Update: Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating induction of fibrosis regression in patients with chronic hepatitis B and liver fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Snippet

Sponsor: RWTH Aachen University | Conditions: Hepatitis B, Chronic, Liver Fibrosis | Phase 4 | Status: TERMINATED